KMI
63
4
JCI
54
2
WFC
82
2
DOW
44
4
DTE
67
2
AVB
54
4
MTCH
35
-4
UNP
55
2
EMN
56
-4
DE
49
9
FLS
69
5
NEE
49
5
NWSA
54
2
ETN
78
2
QRVO
43
3
KMX
58
4
GWW
69
5
PFE
32
4
FMC
39
3
URI
72
4
KMI
63
4
JCI
54
2
WFC
82
2
DOW
44
4
DTE
67
2
AVB
54
4
MTCH
35
-4
UNP
55
2
EMN
56
-4
DE
49
9
FLS
69
5
NEE
49
5
NWSA
54
2
ETN
78
2
QRVO
43
3
KMX
58
4
GWW
69
5
PFE
32
4
FMC
39
3
URI
72
4
Financhill
Back

Madrigal Pharmaceuticals Vs. Kymera Therapeutics Industry Stock Comparison

Sell
46

MDGL
Madrigal Pharmaceuticals

Last Price:
210.34
Seasonality Move:
24.38%
Buy
71

KYMR
Kymera Therapeutics

Last Price:
46.27
Seasonality Move:
65.72%
Sell
46
Madrigal Pharmaceuticals (MDGL) is a Sell

Is Madrigal Pharmaceuticals a Buy, Sell or Hold?

  • The current Madrigal Pharmaceuticals [MDGL] share price is $215.60. The Score for MDGL is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
  • MDGL is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
71
Kymera Therapeutics (KYMR) is a Buy

Is Kymera Therapeutics a Buy, Sell or Hold?

  • The current Kymera Therapeutics [KYMR] share price is $49.02. The Score for KYMR is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
  • KYMR is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

MDGL Stock Price Chart

What is Madrigal Pharmaceuticals's stock price today?

  • The Madrigal Pharmaceuticals share price today is $215.60
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MDGL is experiencing slight selling pressure.

KYMR Stock Price Chart

What is Kymera Therapeutics's stock price today?

  • The Kymera Therapeutics share price today is $49.02
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KYMR is experiencing buying pressure, which is a positive indicator for future bullish movement.

MDGL Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -6.15 Sell
Relative Strength Index (14 RSI): 42.37 Sell
Chaikin Money Flow: -61712 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (209.3 - 231.04) Sell
Bollinger Bands (100): (225.94 - 277.3) Sell

KYMR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.28 Sell
Relative Strength Index (14 RSI): 59.12 Buy
Chaikin Money Flow: 317205 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (43.81 - 49.49) Buy
Bollinger Bands (100): (34.86 - 47.92) Buy

MDGL Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 214.37 Buy
20-day SMA: 216.38 Sell
50-day SMA: 233.07 Sell
200-day SMA: 241.46 Sell
8-day EMA: 214.5 Buy
20-day EMA: 218.29 Sell
50-day EMA: 231.24 Sell
200-day EMA: 235.53 Sell

KYMR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 44.58 Buy
20-day SMA: 46.67 Buy
50-day SMA: 46.11 Buy
200-day SMA: 38.62 Buy
8-day EMA: 45.67 Buy
20-day EMA: 45.85 Buy
50-day EMA: 45.2 Buy
200-day EMA: 38.5 Buy

Madrigal Pharmaceuticals Earnings Growth & MDGL Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $2.78 per share, a decrease next quarter of $0.00 per share, a decrease this year of $7.97 per share, and an increase next year of $9.41 per share.

Kymera Therapeutics Earnings Growth & KYMR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.23 per share, and a decrease next year of $0.47 per share.

Madrigal Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Kymera Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):